StockData
STMEOTCSurgical & Medical Instruments & ApparatusFiscal year ends May 31

Stimcell Energetics Inc.

Financials through fiscal 2026, year ended May 31, 2026Last filing: 10-Q on Oct 14, 2026
$0.16−0.07 (-29.57%)

Close on Oct 19, 2026

Market cap
$3.42M
P/E (TTM)
–
Dividend yield
–

About Stimcell Energetics

Surgical & Medical Instruments & Apparatus, SIC 3841

Stimcell Energetics Inc. is a biotechnology company dedicated to the research, development, and commercialization of therapeutic and wellness products based on microcurrent technology. Its core proprietary offering is eBalance Technology, designed to deliver bioelectric micro amperage current to support cellular function, assist in general wellness, relieve pain, and help manage complications related to diseases such as diabetes, neuropathy, and high blood pressure. The company develops hardware solutions including the eBalance Pro System, intended for healthcare practitioners in clinical settings, and the eBalance Home System, engineered for direct in-home use by patients.

The business operates as a development-stage company with no full-time employees, relying on its executive officers serving as independent consultants alongside third-party engineering and clinical contractors. Corporate activities and subsidiary operations extend across the United States and Canada, where manufacturing arrangements and clinical studies have taken place. Stimcell Energetics Inc. maintains its corporate incorporation under the laws of the State of Nevada.

Summary of the business section of Stimcell Energetics's latest annual report, written by StockData.

Company profile

Company

Legal name
Stimcell Energetics Inc.
Founded
2010
Headquarters
Vancouver, A1
Address
820 - 1130 Pender Street, West V6E 4A4
Phone
(844) 238-2692
Employees
1, May 31, 2015
Industry
Surgical & Medical Instruments & Apparatus
Incorporated in
Nevada
Fiscal year ends
May 31
Auditor
DMCL LLP, Vancouver, Canada

Stock & identifiers

Ticker
STME
Exchange
OTC
Shares outstanding
21M, Aug 31, 2026
Public float
$2.43M, Nov 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
1-for-15 reverse, Jan 14, 2025; 1-for-15 reverse, Nov 5, 2024
SEC CIK
1493712
EIN
38-3939625

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Amir VahabzadehDirector4,164,566

Corporate history

Events identified from SEC filings

DateEventDetails
Jan 15, 2026Late filingNotification of late filing
Sep 2, 2025Late filingNotification of late filing
Oct 15, 2024Name changeName changed from Cell MedX Corp. to Stimcell Energetics Inc.
Aug 29, 2023Late filingNotification of late filing
Aug 29, 2022Late filingNotification of late filing
Aug 31, 2020Late filingNotification of late filing
Aug 30, 2019Late filingNotification of late filing
Apr 16, 2019Late filingNotification of late filing
Aug 30, 2018Late filingNotification of late filing
Aug 29, 2016Late filingNotification of late filing
Sep 1, 2015Late filingNotification of late filing
Dec 24, 2014Auditor changeChange in certifying accountant (8-K Item 4.01)
Dec 3, 2014Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Oct 9, 2014Name changeName changed from Sports Asylum, Inc. to Cell MedX Corp.
Apr 14, 2014Late filingNotification of late filing
Mar 24, 2014Name changeName changed from Plandel Resources, Inc. to Sports Asylum, Inc.
Jan 15, 2013Late filingNotification of late filing
Oct 19, 2012Auditor changeChange in certifying accountant (8-K Item 4.01)